Ads
related to: stroke journals impact factor ranking
Search results
Results From The WOW.Com Content Network
Stroke is a peer-reviewed medical journal published monthly by ... the journal has a 2016 impact factor of 6.032, ranking it 16th out of 192 journals in ...
It was established in 1991 and is published by Elsevier on behalf of the National Stroke Association and the Japan Stroke Society, of which it is the official journal. The editor-in-chief is Fernando D Testai (University of Illinois Chicago). According to the journal's website, it has a 2021 impact factor of 2.677.
A study published in 2021 compared the Impact Factor, Eigenfactor Score, SCImago Journal & Country Rank and the Source Normalized Impact per Paper, in journals related to Pharmacy, Toxicology and Biochemistry. It discovered there was "a moderate to high and significant correlation" between them. [25]
A journal's SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige.
The papers introducing the ranking have been quoted extensively by authors working in Bibliometrics and Scientometrics.For example, reference [3] describing an update to the methodology of this index number is cited [12] from authors publishing in journals such as SAGE's Research on Social Work Practice, [10] Elsevier's Perspectives in Ecology and Conservation, [13] Springer's Forensic Science ...
Therefore, she added, “swapping regular salt for a potassium-enriched salt substitute offers a low-effort, high-impact solution for stroke survivors.” Improving your sodium-potassium ratio for ...
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
“As with all research, finding a greater sample of people affected by these conditions using GLP-1 medications may help to identify risk factors for these types of problems,” Ali added.